Title:
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER STEM CELL
Document Type and Number:
WIPO Patent Application WO/2019/160312
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition capable of treating cancer stem cells by suppressing invasive and metastatic characteristics of cancer cells, inter alia, cancer stem cells.
Inventors:
KANG SEOK GU (KR)
LEE JI HYUN (KR)
KIM YONG CHUL (KR)
CHO KYUNGRAE (KR)
LEE JI HYUN (KR)
KIM YONG CHUL (KR)
CHO KYUNGRAE (KR)
Application Number:
PCT/KR2019/001733
Publication Date:
August 22, 2019
Filing Date:
February 13, 2019
Export Citation:
Assignee:
UNIV YONSEI IACF (KR)
International Classes:
A61K31/13; A61K31/47; A61P35/00
Domestic Patent References:
| WO2005014529A1 | 2005-02-17 | |||
| WO2004105798A1 | 2004-12-09 |
Foreign References:
| KR20170085170A | 2017-07-24 | |||
| CN107663159A | 2018-02-06 | |||
| US20030144293A1 | 2003-07-31 |
Other References:
GIANNUZZO, A. O: "Targeting of the P2X7 receptor in pancreatic cancer and stellate cells", INTERNATIONAL JOURNAL OF CANCER, 2016, pages 2540 - 2552, XP055632057
SEELAND, S.: "ATP-induced cellular stress and mitochondrial toxicity in cells expressing purinergic P2X7 receptor", PHARMACOLOGY RESEARCH & PERSPECTUVES, 2015, pages 1 - 13, XP055632060
SEELAND, S.: "ATP-induced cellular stress and mitochondrial toxicity in cells expressing purinergic P2X7 receptor", PHARMACOLOGY RESEARCH & PERSPECTUVES, 2015, pages 1 - 13, XP055632060
Attorney, Agent or Firm:
LEE, Jae Young (KR)
Download PDF: